How to Evaluate a Research Peptide Supplier

Why does supplier evaluation matter so much here?

The research-chemical market is not regulated the way medicines are. There is no marketing authorisation to lose, no inspectorate performing routine audits, and in most cases no consequence for a supplier whose material does not match its label. Independent testing across the sector has repeatedly turned up material that is underdosed, mislabelled, or substituted with a different compound entirely — and fabricated or unverifiable certificates are a well-documented problem.

You cannot assess a lyophilised peptide by looking at it. Two vials of white powder are indistinguishable by eye whether one is 99% pure target compound and the other is largely excipient. The documentation is therefore not paperwork around the product — for practical purposes it is the product, and evaluating a supplier means evaluating the quality and verifiability of what they can show you.

How do you read a Certificate of Analysis?

The CoA is the single most important document a supplier provides. A real one identifies the compound and lot, states the analytical methods used, and reports quantitative results — not just a pass/fail stamp. The table below lists what a complete certificate reports, what each entry actually tells you, and the corresponding warning sign.

One distinction is worth being explicit about: a sample or typical result certificate is not a CoA. It demonstrates what the supplier’s material looked like on some occasion, not what is in the vial being shipped to you. Batch-specific documentation is the minimum meaningful standard.

What do HPLC and mass spectrometry actually tell you?

These two methods answer two genuinely different questions, and a supplier providing only one is leaving half the picture unmeasured.

HPLC — high-performance liquid chromatography — separates the sample so that the target compound and its impurities elute at different times and appear as distinct peaks. Purity is normally reported as the target peak’s area as a percentage of total peak area, usually with UV detection; for peptides, detection around 215 nm is common because that wavelength responds to the peptide bond itself. This answers how much of what is here is the thing I want.

Mass spectrometry answers the prior question — is this the right molecule at all — by measuring molecular mass. For peptides, electrospray ionisation produces a series of multiply-charged ions which are deconvoluted to give the intact molecular mass; if the observed mass corresponds to the theoretical mass of the target within the instrument’s tolerance, identity is confirmed.

A supplier who provides both, with the actual traces rather than just two numbers, is demonstrating quality rather than asserting it. Chromatograms are difficult to fabricate convincingly; a number in a table is not.

What is net peptide content, and why is it not the same as purity?

This is the most commonly misunderstood item on a peptide CoA, and the one most often omitted entirely. HPLC purity and net peptide content are different quantities, and a high figure for one does not imply a high figure for the other.

HPLC purity is relative: of the material that the detector saw, what proportion was the target? Net peptide content is absolute: of the total mass in the vial, how much is actually peptide? The gap between them exists because a lyophilised synthetic peptide is not pure peptide by mass. It also contains counterion salt, residual water, and other non-peptide mass that a UV chromatogram does not register.

The counterion is the largest contributor. Trifluoroacetic acid is used both as a cleavage reagent in solid-phase peptide synthesis and as an ion-pairing agent during reversed-phase HPLC purification, so synthetic peptides are commonly delivered as TFA salts. Trifluoroacetate binds to positively charged sites on the molecule — the N-terminal amine and the side chains of arginine and lysine residues — meaning a peptide with several basic residues carries proportionally more counterion mass. Residual TFA can be quantified by ion chromatography, ¹⁹F-NMR, FT-IR, or HPLC-ELSD.

The practical consequence: a vial can legitimately be described as 99% pure by HPLC while containing meaningfully less peptide by mass than the label figure suggests. Neither number is dishonest on its own. Reporting only the flattering one, without stating which quantity is being reported, is where transparency breaks down. If a supplier’s CoA gives a single percentage with no indication of whether it is chromatographic purity or net peptide content, that is worth asking about.

What about endotoxin and residual solvents?

Both are legitimate quality dimensions that most research-peptide CoAs omit. They are worth understanding partly so you can ask about them, and partly so you can recognise when a supplier is quoting a threshold that does not mean what they imply.

Endotoxin

Bacterial endotoxins are lipopolysaccharides from the outer membrane of Gram-negative bacteria. They are measured by the bacterial endotoxins test — the LAL assay — described in USP General Chapter <85>, which recognises gel-clot, turbidimetric, and chromogenic techniques.

Here is the part that is routinely misstated online: endotoxin limits are set per product and per application in individual monographs, derived from the intended route of administration and dose. There is no single universal “acceptable EU/mg” figure that applies to research peptides generally, despite specific numbers being widely repeated as though there were. A supplier quoting a hard limit should be able to say which monograph or calculation it comes from. If they cannot, the number is decoration.

Residual solvents

Peptide synthesis and purification use organic solvents, and traces remain in the finished material. The reference framework is the ICH Q3C guideline on residual solvents, which sorts them into three classes:

• Class 1 — to be avoided. Known toxicants such as benzene and carbon tetrachloride, permitted only where use is unavoidable and justified.
• Class 2 — to be limited. Solvents with significant toxicity, controlled against permitted daily exposure values. This class includes acetonitrile, the solvent most relevant to reversed-phase peptide HPLC, along with methanol and toluene.
• Class 3 — low toxic potential. Solvents such as ethanol and acetone, where amounts of 50 mg per day or less — corresponding to 5,000 ppm, or 0.5% — are considered acceptable without further justification.

Residual solvent data is rarely supplied for research-grade peptides, and its absence is not by itself a red flag. But a supplier who can discuss the framework coherently is demonstrating a different level of analytical literacy from one who cannot.

Third-party or in-house testing — does it matter?

In-house testing is normal and fine; many capable suppliers run their own analytics. Independent third-party verification is stronger, for the straightforward reason that it removes a conflict of interest — a supplier grading its own homework has an obvious incentive problem, however honest it may in fact be.

A further signal is whether the testing laboratory’s competence has been externally assessed. ISO/IEC 17025 is the international standard for the competence, impartiality, and consistent operation of testing and calibration laboratories. Accreditation to it means an external body has evaluated staff qualifications, equipment calibration, methods, and quality management — rather than the laboratory asserting competence on its own authority. In the UK the national accreditation body is UKAS. Accreditation is a meaningful positive signal; its absence is not automatically disqualifying for a research reagent, but it is a question worth asking.

The strongest signal of all is not which testing route a supplier uses, but how they react to being asked. A supplier who provides independent certificates on request and treats the question as reasonable is telling you something useful about how they operate.

What does batch traceability actually require?

Every batch should carry a unique lot number, that lot number should appear on both the vial and its certificate, and the supplier should retain reference samples so any batch can be re-tested if a question arises later. Retained samples are the part most often missing: without them, a dispute about material shipped six months ago cannot be resolved by measurement, only by assertion.

Traceability is what separates a controlled operation from someone decanting bulk material of unknown provenance into unlabelled vials. It is also the mechanism that makes a recall possible at all — a supplier who cannot identify which customers received which lot cannot act on a problem even if they want to.

How much do storage and cold chain matter?

Peptide integrity depends on storage and transit conditions, and a certificate describes the material as it was when tested — not necessarily as it arrives. Lyophilised peptides are generally stored at 2–8 °C away from direct light, and degradation pathways including hydrolysis and oxidation accelerate with temperature and moisture exposure.

Ask how material is stored at rest, whether cold chain is maintained in transit, and what stability data supports the answer. A supplier who can answer specifically — with data and conditions rather than reassurance — is operating a real quality function. A supplier whose answer is that peptides are “quite stable” has told you they are not measuring.

Why is buyer verification a good sign rather than an obstacle?

It can feel like friction, but a supplier that verifies who its buyers are and restricts supply to bona fide research use is demonstrating an active compliance function — and compliance discipline correlates strongly with the operational discipline that produces reliable material. The same organisational habits that maintain buyer records, research-use confirmations, and honest regulatory language tend to be the ones that maintain lot numbering and retained samples.

The inverse is a stronger signal still. A supplier willing to sell an investigational compound to anyone, with marketing that implies human use, has told you it is comfortable operating outside the rules that apply to it. There is no particular reason to expect that comfort stops at the marketing copy and does not extend to the analytics.

What are the red flags?

What should you ask a supplier before ordering?

These eight questions can be sent verbatim. The answers — and the willingness to answer at all — will separate suppliers faster than any amount of website copy.

1. Can you provide the CoA for the specific lot I would receive, not a sample certificate?
2. What analytical methods produced the purity figure, and can I see the HPLC chromatogram and MS trace?
3. What was the expected molecular weight, and what mass was observed?
4. Is the reported figure chromatographic purity, net peptide content, or both?
5. Is testing in-house, third-party, or both — and is the laboratory accredited?
6. What is your lot-numbering and retained-sample policy?
7. How is material stored and shipped, and what stability data supports that?
8. What is your buyer-verification and research-use policy?

Frequently asked questions

How does RETApro meet this standard?

Rather than assert it, here is the evidence measured against the checklist above. RETApro’s current retatrutide lot is tested by PeptideVerify by HPLC–UV (215 nm) on a Shimadzu LCMS-8040 · PDA, reporting 98.0% HPLC purity against an expected mass of 4,731.41 Da. The certificate carries a unique ID (PV-8B67BB-HAJY, issued 6 July 2026). Every order ships cold-chain, and supply is restricted to bona fide research use.

The part we would draw attention to is not the purity figure — every supplier in this market quotes a high one. It is that our certificate is verifiable against the issuing laboratory’s own record, via its certificate ID and a SHA-256 integrity hash. A PDF handed over by a seller can be edited; a record held by the laboratory that issued it cannot be edited by us. That is the difference between showing you a document and letting you check one.

Applying our own standard honestly: the instrument used is a triple-quadrupole system, so mass confirmation sits in the ±1 Da class described above rather than the high-resolution ppm class — appropriate for routine identity confirmation, and stated plainly rather than dressed up. Net peptide content and residual solvent data are not currently reported on our certificate; if that matters for your application, ask us and we will tell you what we do and do not have rather than improvise a number.